Literature DB >> 18989880

Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.

Andrea D Orsey1, Jean B Belasco, Jonas H Ellenberg, Kathryn H Schmitz, Chris Feudtner.   

Abstract

BACKGROUND: Opioids are a cornerstone of palliation of pain. We sought to assess variation in opioid prescription during the last week of life among a cohort of pediatric oncology patients who died while hospitalized. PROCEDURE: We used detailed hospital administrative data from the Pediatric Health Information System (PHIS) regarding 1,466 subjects 0-24 years of age who were treated at 33 hospitals between 2001 and 2005.
RESULTS: Among the 1,466 subjects hospitalized at the time of their death, 56% received opioids every day during the hospitalized portion of their last week of life, while 44% did not. This proportion varied substantially across hospitals (range 0-90.5%). After multivariate adjustment for individual-level characteristics, the hospital-level effect on the odds of continuous prescription of opioids during the hospitalized portion of the last 7 days of life continued to vary significantly among hospitals, accounting for 10.5% of the variance in the receipt of daily opioid (P < 0.001).
CONCLUSION: Opioid prescription during the hospitalized portion of the last week of life varies substantially among hospitals, even after adjustment for clinical characteristics of the patients. The reasons for this significant variation, especially the component explained by hospital-level and not patient-level factors, warrant more scrutiny. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18989880     DOI: 10.1002/pbc.21824

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.

Authors:  Marko Kavcic; Brian T Fisher; Yimei Li; Alix E Seif; Kari Torp; Dana M Walker; Yuan-Shung Huang; Grace E Lee; Sarah K Tasian; Marijana Vujkovic; Rochelle Bagatell; Richard Aplenc
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

2.  Health Care Reform and Concurrent Curative Care for Terminally Ill Children: A Policy Analysis.

Authors:  Lisa C Lindley
Journal:  J Hosp Palliat Nurs       Date:  2011-03       Impact factor: 1.918

3.  Pediatric polypharmacy: time to lock the medicine cabinet?

Authors:  Nancy E Morden; David Goodman
Journal:  Arch Pediatr Adolesc Med       Date:  2011-09-05

4.  Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database.

Authors:  Marko Kavcic; Brian T Fisher; Kari Torp; Yimei Li; Yuan-Shung Huang; Alix E Seif; Marijana Vujkovic; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2012-11-28       Impact factor: 3.167

5.  Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia.

Authors:  Kelly D Getz; Tamara P Miller; Alix E Seif; Yimei Li; Yuan-Shung V Huang; Brian T Fisher; Richard Aplenc
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

6.  Documentation of breakthrough pain in narrative clinical records of children with life-limiting conditions: Feasibility of a retrospective review.

Authors:  Linda Jm Oostendorp; Dilini Rajapakse; Paula Kelly; Joanna Crocker; Andrew Dinsdale; Lorna Fraser; Myra Bluebond-Langner
Journal:  J Child Health Care       Date:  2018-11-21       Impact factor: 1.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.